FDmiX: Fast, robust series production of nanoparticles
Nucleic acid-based medications such as mRNA vaccines offer tremendous po-tential for medicine and are opening up new therapeutic approaches. These active ingredients must be enclosed inside nanoparticles to ensure that they get to where they are needed inside the body’s cells. The Fraunhofer Institute for Production Systems and Design Technology IPK and FDX Fluid Dynamix GmbH have worked together to develop a technology platform for the pro-duction of nanoparticles that can achieve particle qu...
Dynamix Gmb Christoph Hein Fraunhofer Dynamic Mixing Technologies Dynamix Gmbh High Precision Technology
Source: fraunhofer.de